Amgen Inc, (AMGN)

#1

Amgen Inc. has offered to purchase up to 10 Billion USD of its outstanding common stock through a Dutch Auction tender offer.

The terms of the offer are as follows (subject to proration):

Minimum bid: 175.00 USD
Maximum bid: 200.00 USD
Accepted bid increment: 1.00 USD

The below options are available to a shareholder:

Option 1 - Take no action

Option 2 - Tender shares at No Specified Price (NSP), less any applicable withholding taxes

Option 3 - Tender shares at Bid Price, less any applicable withholding taxes

Holders wishing to tender their shares at a minimum bid price should make an election under the No Specified Price option, as such an election will be deemed to have been tendered at the minimum bid price.

In order to submit shares at a bid price, shareholders should click on the Change link on the applicable choice line below. This will navigate the user to a new box where both the share quantity and applicable bid price should be entered.

Odd lot priority: No

Conditional Tender Offered: Yes
Conditional Tender Terms: Holder may tender with the condition that a minimum share amount is accepted by the offeror. Shareholders whose shares are conditionally tendered must have tendered all their shares.

Should a holder wish to make a conditional tender instruction, a ticket must be submitted to Customer Service stating the minimum quantity to be accepted. Failure to do so will result in the election being processed with no conditions.

Guaranteed Delivery: Yes
Last day to purchase shares and be eligible to tender: 2018-03-05

The deadline to submit shares to the offer will be 2018-03-05 @ 13:00 (America/New_York).

In the absence of an election, no action will be taken

0 me gusta

#2

Hola,

Le he estado echando un ojo. Este es el historial de dividendos de su web:

http://investors.amgen.com/phoenix.zhtml?c=61656&p=irol-dividends

Y aquí el gráfico de evolución del dividendo de Dividend Channel:

image

Un incremento de casi el 23% anualizado.

El “problema” para mi es el sector. Os he leído más de una vez de que las biotecnológicas son bastante impredecibles. ¿Alguien la lleva? ¿Opiniones? ¿Apta para largo plazo o más para buscar revalorización?

0 me gusta

#3

Hace unos días comentaban que era una de las empresas que mejor habían aguantado las turbulencias en los últimos años:

Y la gráfica parece corroborarlo:

image

0 me gusta

#4

Estas operaciones son interesantes. Básicamente porque las empresa te está diciendo que sus acciones están baratas desde su punto de vista. El sector de la biotecnología y concretamente las tres grandes ( Amgen, Gild y Biogen) se encuentran a unos precios atractivos en este momento.

0 me gusta